Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
Br J Haematol
; 196(5): 1184-1193, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34951009
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Tumor Suppressor Protein p53
/
Lymphoma, Large B-Cell, Diffuse
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2022
Type:
Article
Affiliation country:
Italy